The FDA cleared Novartis gene therapy Zolgensma in infants with the genetic disease SMA. Its price tag, $2.1 million, can be paid out over five years and comes with a partial performance-based rebate.
JP Morgan Chase cuts ties with Purdue Pharma; Amazon looks into health-tracking wearable; Proposed Senate package tackles surprise medical bills, pricing.
The chief communications officer discusses J&J’s agency relationships amid recent budget cuts.
The FDA under Sharpless; Lilly sells half-price version of insulin; Maine confirms measles case.
The Senate may not take up a confirmation vote before the 2020 election, but one Beltway insider predicts the FDA will still be potent during the transition to a new commissioner.
Science Studio will help the brand engage students — and help them with their homework.
Verily partners with pharma companies on clinical trials; J&J loses another talc lawsuit; Vaccine alliance head calls for online misinformation to be deleted.
Incisive Health has been bought by the agency and clinical services giant UDG Healthcare for $17.7 million.
A postmortem on the Entresto launch reveals some lessons in value-based contracting.
Healthcare communications group Huntsworth has announced the purchase of two healthcare research and communications businesses in a multi-million-dollar double swoop.